Definitive diagnosis of multiple system atrophy of the cerebellar type (MSA-C) is challenging. We hypothesized that rates of change of pons and middle cerebellar peduncle (MCP) diameters on MRI would be unique to MSA-C and serve as diagnostic biomarkers.
We defined the normative data for anterior-posterior (AP) pons and transverse MCP diameters on brain MRI in healthy controls, performed diameter-volume correlations, and measured intra-and inter-rater reliability. We studied an Exploratory cohort (2002-2014) of 88 MSA-C and 78 other cerebellar ataxia patients, and a Validation cohort (2015-2021) of 49 MSA-C, 13 MSA-P, 99 other cerebellar ataxia patients, and 314 non-ataxia patients. We measured AP Pons and MCP diameters on baseline and subsequent MRIs, and correlated results with Brief Ataxia Rating Scale scores. We assessed midbrain:pons and MCP:pons ratios over time.
The normative AP Pons diameter was 23.6±1.6 mm, and MCP diameter 16.4±1.4 mm. Pons diameter correlated with volume, r=0.94, p<0.0001.
The AP Pons and MCP measures were smaller at first scan in MSA-C compared to all other ataxias. AP Pons diameter: Exploratory, 19.3±2.6 mm vs. 20.7±2.6 mm, Validation, 19.9±2.1 mm vs 21.1±2.1 mm. MCP transverse diameter, Exploratory, 12.0±2.6 mm vs. 14.3±2.1 mm, Validation, 13.6±2.1 mm vs 15.1±1.8 mm, all p<0.001.
The AP Pons and MCP rates of change were faster in MSA-C than in all other ataxias. AP Pons diameter rates of change: Exploratory, -0.87±0.04 mm/year vs. -0.09±0.02 mm/year, Validation, -0.89±0.48 mm/year vs. -0.10±0.21 mm/year. MCP transverse diameter rates of change: Exploratory, -0.84±0.05 mm/year vs. -0.08±0.02 mm/year, Validation, -0.94±0.64 mm/year vs -0.11±0.27 mm/year, all values p<0.0001.
AP Pons and MCP diameters were indistinguishable between Possible, Probable, and Definite MSA-C. The rate of AP Pons atrophy was linear, correlating with ataxia severity.
Using a lower threshold AP Pons diameter decrease of -0.4 mm/year to balance sensitivity and specificity, area under the curve analysis (AUC) discriminating MSA-C from other ataxias was 0.94, yielding sensitivity 0.92 and specificity 0.87. For the MCP, with threshold decline -0.5 mm/year, AUC was 0.90 yielding sensitivity 0.85 and specificity 0.79.
The Midbrain:pons ratio increased progressively in MSA-C, whereas the MCP:pons ratio was almost unchanged.
AP Pons and MCP diameters were smaller in MSA-C than in MSA-P, p<0.001.
We conclude from this 20-year longitudinal clinical and imaging study that AP Pons and MCP diameters are phenotypic imaging biomarkers of MSA-C. In the correct clinical context, an AP Pons and transverse MCP diameter decline of ∼0.8 mm/year is sufficient for and diagnostic of MSA-C.